**Albert 1974** Albert KS, Sedman AJ, Wagner JG. Pharmacokinetics of orally administered acetaminophen in man. J Pharmacokinet Biopharm. 1974 Oct;2(5):381-93. doi: 10.1007/BF01071309.

**Ameer 1983** Ameer B, Divoll M, Abernethy DR, Greenblatt DJ, Shargel L. Absolute and relative bioavailability of oral acetaminophen preparations. J Pharm Sci. 1983 Aug;72(8):955-8. doi: 10.1002/jps.2600720832. 

**Clements 1984** Clements JA, Critchley JA, Prescott LF. The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man. Br J Clin Pharmacol. 1984 Oct;18(4):481-5. doi: 10.1111/j.1365-2125.1984.tb02495.x.

**Divoll 1982** Divoll M, Abernethy DR, Ameer B, Greenblatt DJ. Acetaminophen kinetics in the elderly. Clin Pharmacol Ther. 1982 Feb;31(2):151-6. doi: 10.1038/clpt.1982.24.

**Dalton 2001** Dalton JT, Straughn AB, Dickason DA, Grandolfi GP. Predictive ability of level A in vitro-in vivo correlation for ringcap controlled-release acetaminophen tablets. Pharm Res. 2001 Dec;18(12):1729-34. doi: 10.1023/a:1013326714345.

**Eandi 1984** Eandi M, Viano I, Ricci Gamalero S. Absolute bioavailability of paracetamol after oral or rectal administration in healthy volunteers. Arzneimittelforschung. 1984;34(8):903-7. 

**Flint 2017** Flint RB, Mian P, van der Nagel B, Slijkhuis N, Koch BC. Quantification of Acetaminophen and Its Metabolites in Plasma Using UPLC-MS: Doors Open to Therapeutic Drug Monitoring in Special Patient Populations. Ther Drug Monit. 2017 Apr;39(2):164-171. doi: 10.1097/FTD.0000000000000379. 

**Jiang 2013** Jiang XL, Zhao P, Barrett JS, Lesko LJ, Schmidt S. Application of physiologically based pharmacokinetic modeling to predict acetaminophen metabolism and pharmacokinetics in children. CPT Pharmacometrics Syst Pharmacol. 2013 Oct 16;2(10):e80. doi: 10.1038/psp.2013.55. 

**Johnson 2018** TN, Bonner JJ, Tucker GT, Turner DB, Jamei M. Development and applications of a physiologically-based model of paediatric oral drug absorption. Eur J Pharm Sci. 2018 Mar 30;115:57-67. doi: 10.1016/j.ejps.2018.01.009. 

**Kuepfer 2016** Kuepfer L, Niederalt C, Wendl T, Schlender JF, Willmann S, Lippert J, Block M, Eissing T, Teutonico D. Applied Concepts in PBPK Modeling: How to Build a PBPK/PD Model.CPT Pharmacometrics Syst Pharmacol. 2016 Oct;5(10):516-531. doi: 10.1002/psp4.12134.

**Liukas 2011** Liukas A, Kuusniemi K, Aantaa R, Virolainen P, Niemi M, Neuvonen PJ, Olkkola KT. Pharmacokinetics of intravenous paracetamol in elderly patients. Clin Pharmacokinet. 2011 Feb;50(2):121-9. doi: 10.2165/11537240-000000000-00000. 

**Mian 2020** Mian P, van den Anker JN, van Calsteren K, Annaert P, Tibboel D, Pfister M, Allegaert K, Dallmann A. Physiologically Based Pharmacokinetic Modeling to Characterize Acetaminophen Pharmacokinetics and N-Acetyl-p-Benzoquinone Imine (NAPQI) Formation in Non-Pregnant and Pregnant Women. Clin Pharmacokinet. 2020 Jan;59(1):97-110. doi: 10.1007/s40262-019-00799-5. 

**Novo Nordisk 2012** Novo Nordisk A/S D, 2012. A Randomised, Placebo-controlled, Double-blind, Incomplete Cross-over Design Trial to Evaluate the Effects of Liraglutide on Gastric Emptying, Energy Expenditure and Appetite, and to Evaluate Liraglutide Pharmacokinetics in Non-diabetic Obese Subjects. Clinical Trial Report Trial ID NN8022-3630.

**Paintaud 1998** Paintaud G, Thibault P, Queneau PE, Magnette J, BÃ©rard M, Rumbach L, Bechtel PR, Carayon P. Intraindividual variability of paracetamol absorption kinetics after a semi-solid meal in healthy volunteers. Eur J Clin Pharmacol. 1998 Jan;53(5):355-9. doi: 10.1007/s002280050393.

**PK-Sim Ontogeny Database Version 7.3** ([https://github.com/Open-Systems-Pharmacology/OSPSuite.Documentation/blob/38cf71b384cfc25cfa0ce4d2f3addfd32757e13b/PK-Sim%20Ontogeny%20Database%20Version%207.3.pdf](https://github.com/Open-Systems-Pharmacology/OSPSuite.Documentation/blob/38cf71b384cfc25cfa0ce4d2f3addfd32757e13b/PK-Sim%20Ontogeny%20Database%20Version%207.3.pdf))	

**Prescott 1980** Prescott LF. Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol. 1980 Oct;10 Suppl 2(Suppl 2):291S-298S. doi: 10.1111/j.1365-2125.1980.tb01812.x. 

**PubChem** https://pubchem.ncbi.nlm.nih.gov/compound/3-Methoxyacetaminophen

**Rawlins 1977** Rawlins MD, Henderson DB, Hijab AR. Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol. 1977 Apr 20;11(4):283-6. doi: 10.1007/BF00607678.

**Schlender 2016** Schlender JF, Meyer M, Thelen K, Krauss M, Willmann S, Eissing T, Jaehde U. Development of a Whole-Body Physiologically Based Pharmacokinetic Approach to Assess the Pharmacokinetics of Drugs in Elderly Individuals. Clin Pharmacokinet. 2016 Dec;55(12):1573-1589. 	

**Souliman 2006** Souliman S, Blanquet S, Beyssac E, Cardot JM. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form. Eur J Pharm Sci. 2006 Jan;27(1):72-9. doi: 10.1016/j.ejps.2005.08.006.  

**Statelova 2020** Statelova M, Holm R, Fotaki N, Reppas C, Vertzoni M. Successful Extrapolation of Paracetamol Exposure from Adults to Infants After Oral Administration of a Pediatric Aqueous Suspension Is Highly Dependent on the Study Dosing Conditions. AAPS J. 2020 Sep 30;22(6):126. doi: 10.1208/s12248-020-00504-6.

**van der Veen 1994** van der Veen J, Eissens AC, Lerk CF. Controlled release of paracetamol from amylodextrin tablets: in vitro and in vivo results. Pharm Res. 1994 Mar;11(3):384-7. doi: 10.1023/a:1018956819404. 

**Volak 2013** Volak LP, Hanley MJ, Masse G, Hazarika S, Harmatz JS, Badmaev V, Majeed M, Greenblatt DJ, Court MH. Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers. Br J Clin Pharmacol. 2013 Feb;75(2):450-62. doi: 10.1111/j.1365-2125.2012.04364.x. 